Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

InMed Pharmaceuticals Inc.

NASDAQ: MTRI · Life Sciences · 12 alerts · CIK 1728328

Share price
$19.87Close, Nov 16
Market cap
$109M
Shares outstanding
5.49MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All InMed Pharmaceuticals Inc. filings on SEC EDGAR ↗

5:12 PM ET 8-K
Nasdaq/NYSE Compliance Notice

InMed Pharmaceuticals Nasdaq/NYSE Compliance Notice

InMed Pharmaceuticals received a deficiency notice from Nasdaq for failing to maintain the minimum $2.5 million shareholders' equity requirement for continued listing. The company reported shareholders' equity of $1,075,007, largely due to expenses related to its pending merger with Mentari Therapeutics. InMed expects to regain compliance upon the closing of the merger, which is anticipated to bring approximately $490 million in gross proceeds to the combined company.

Counterparty
The Nasdaq Stock Market LLC
Term
45 days to submit plan

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.